This week, we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine‑associated vasculitis. When rare events hide in noise, only scale can reveal the signal. Can population‑level data finally bring this paradox into focus?
From missed opportunities to equitable access: Can STEPS redesign the kidney transplant pathway?
Searchin’ For My Lost Shaker of Salt- Targeted Treatment of Hyponatremia
Is REACT (Renal Autologous Cell Therapy) the “fifth pillar” in diabetic kidney disease?
2026 KDIGO Anemia Management Guidelines
To INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients
POTCAST- K+ Pop and Arrhythmia Drop
A VALIANT effort to combat complement disorders with pegcetacoplan
Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D
Fish Oil in Dialysis: A Big Catch or an Empty Net
Attacking the Origin of IgAN: ORIGIN3 and Atacicept
Kidney Week in Houston: Day 2
Kidney Week in Houston: Day 1
2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully
The Protein Pendulum in CKD: supplement or restrict?
Chimerism and Immune Tolerance: Can We Says Goodbye to Immunosuppression?
PREVENT, Detect, Treat: What’s New in the 2025 Hypertension Toolkit
In ESRD is spironolactone an overACHIEVEr?
#NephJC Summer Bookclub: Everything is Tuberculosis by John Green
The summer book club started in 2015, with one of the best books we have done in book club, Atul Gawande's Being Mortal. I think it should be required reading for all physicians. So now, in 2025, it is the NephJC Summer Book’s tenth anniversary (which represents our eleventh book). The history has been rich:
















